Interested in Tool Compounds to Explore Neurodegenrative Conditions (Avilex Pharma)

il y a 2 ans

Avilex Pharma

Start-up

Créateur



Recherche partenariat

Recherche partenaire principal


Avilex Pharma is specialized in designing and developing peptide based inhibitors targeting PDZ domain proteins, in particular PSD-95, which is a post-synaptic density protein involved in neurodegenerative disorders. Avilex Pharma offers the provision of novel tool compounds to explore and evaluate in models of such conditions. Thus, Avilex Pharma – as a chemical synthesis expert – seeks biological partners in the neuroscience area to examine novel neuroprotective drug-like compounds in relevant in vitro and in vivo models of neurodegenerative diseases, thereby collaborating to gain fundamental mechanistic insights into the complex pathology of synaptic signalling.


 Innovation
 Start-up
 Transfert de technologie
 Médicaments
 Innovation & Recherche
 Biotechnologie médicale
 Chimie
 Recherche

Appels recommandés pour cette idée
Si vous connaissez un appel qui peut correspondre à cette idée

Recommander un appel